Keywords: novartis, elidel, cleared, first, market, food, drug

Novartis' Elidel cleared in first market

Article | 14 December 2001

Print This

The US Food and Drug Administration has approved Novartis' Elidel(pimecrolimus) for use in atopic dermatitis, a few days in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in